Immerge Biotherapeutics, Inc.
Records under this name other than patents Immerge Biotherapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Immerge Biotherapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,547,522 | Method to enrich for α(1,3)-galactosyltransferase null pig cells Term ended Term ended Feb 10, 2024 · USPTO record | Term ended | Term ended Feb 10, 2024 | USPTO record |
| US 7,547,816 | ALPHA(1,3)-GALACTOSYLTRANSFERASE Knockout Swine, Tissues and Organs Term ended Term ended Sep 11, 2023 · High confidence | Term ended | Term ended Sep 11, 2023 | High confidence |
| US 6,461,811 | Gamma-herpes virus DNA and methods of use Term ended Term ended Jul 7, 2020 · USPTO record | Term ended | Term ended Jul 7, 2020 | USPTO record |
| US 6,942,863 | Gamma herpesvirus DNA and methods of use Lapsed on the fee record Ended Sep 13, 2013 · USPTO record | Lapsed on the fee record | Ended Sep 13, 2013 | USPTO record |
| US 6,867,347 | Swine defective for transmission of porcine endogenous retrovirus and uses thereof Lapsed on the fee record Ended Mar 15, 2013 · USPTO record | Lapsed on the fee record | Ended Mar 15, 2013 | USPTO record |